Screener
Lyell Immunopharma, Inc. LYEL Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$4.0KBeat by $375.0
EPS-$1.92Miss by $0.02
Revenue estimate$3.6K
EPS estimate-$1.90
Next report
Nov 10, 2026 (in 2 months)Revenue estimate$3.8K
EPS estimate-$2.06
Versus estimates
Revenue
Q2 2026$4.0KBeat by $375.0
Q1 2026$2.0KMiss by $1.0KQ4 2025$6.0KMiss by $9.3KQ3 2025$15.0KQ2 2025$8.0KBeat by $4.0KQ1 2025$7.0KDiluted EPS
FAQ
- When did Lyell Immunopharma, Inc. report Q2 2026 earnings?
- Lyell Immunopharma, Inc. (LYEL) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Lyell Immunopharma, Inc.'s Q2 2026 revenue and EPS?
- Lyell Immunopharma, Inc. reported revenue of $4.0K and eps of $-1.92 for Q2 2026.
- Did Lyell Immunopharma, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $3.6K by $375.0. EPS missed the consensus estimate of $-1.90 by $0.02.
- How did Lyell Immunopharma, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 50.0% from $8.0K a year earlier and eps grew 33.6% from $-2.89.
- Where can I find Lyell Immunopharma, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-054330) and the 10-Q periodic report (0001628280-26-054367) directly on SEC EDGAR. The filing index links above go to sec.gov.
